Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (301-310 of 499) with videos related to

Pageof 50
Sort By:
Cancers|September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas CancerLukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Journal for Immunotherapy of Cancer|May 31, 2024
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 studyMichael J Overman, Fabio Gelsomino, Massimo Aglietta, et al.
JCO Precision Oncology|March 23, 2022
Landscape of <i>KRAS</i><sup>G12C</sup>, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in <i>KRAS</i>-Mutated CancersMohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluationRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Diseases of the Colon and Rectum|July 15, 2021
Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical TrialFrancesc Balaguer, Elena M Stoffel, Carol Ann Burke, et al.
EJNMMI Reports|May 14, 2025
Comparison of inter- and intraobserver agreement between [<sup>18</sup>F]AlF-NOTA-octreotide and [<sup>68</sup>Ga]Ga-DOTA-SSA PET/CTHannes Leupe, Niloefar Ahmadi Bidakhvidi, Karolien Goffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis, Koji Oba, Xavier Paoletti, et al.
Investigational New Drugs|June 22, 2026
Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 studyWilliam P Harris, Pilar García-Alfonso, Jean Phillipe Metges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trialsEmmanuel Mitry, Anthony L A Fields, Harry Bleiberg, et al.
Pageof 50

Showing results (301-310 of 499) with videos related to

Sort By:
Pageof 50
Cancers|September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas CancerLukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Journal for Immunotherapy of Cancer|May 31, 2024
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 studyMichael J Overman, Fabio Gelsomino, Massimo Aglietta, et al.
JCO Precision Oncology|March 23, 2022
Landscape of <i>KRAS</i><sup>G12C</sup>, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in <i>KRAS</i>-Mutated CancersMohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluationRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Diseases of the Colon and Rectum|July 15, 2021
Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical TrialFrancesc Balaguer, Elena M Stoffel, Carol Ann Burke, et al.
EJNMMI Reports|May 14, 2025
Comparison of inter- and intraobserver agreement between [<sup>18</sup>F]AlF-NOTA-octreotide and [<sup>68</sup>Ga]Ga-DOTA-SSA PET/CTHannes Leupe, Niloefar Ahmadi Bidakhvidi, Karolien Goffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis, Koji Oba, Xavier Paoletti, et al.
Investigational New Drugs|June 22, 2026
Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 studyWilliam P Harris, Pilar García-Alfonso, Jean Phillipe Metges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trialsEmmanuel Mitry, Anthony L A Fields, Harry Bleiberg, et al.
Pageof 50